Prednisone

About

Therapy type: Chemotherapy

Therapy strategy: Corticosteroid

Mappings

NCI Thesaurus: Prednisone (ncit:C770)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) BARD1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) BRIP1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) BRIP1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) CDK12 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Niraparib, Prednisone
Sensitivity (+) CD30 + Anaplastic Large Cell Lymphoma Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Sensitivity (+) BRCA1 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA1 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA2 oncogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BRCA2 pathogenic variants Prostate Adenocarcinoma Abiraterone acetate, Olaparib, Prednisone
Sensitivity (+) BCR::ABL1 Acute Lymphoid Leukemia Cytarabine, Methotrexate, Ponatinib, Prednisone, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
Sensitivity (+) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
Sensitivity (+) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
Sensitivity (+) CD20 + Burkitt Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
Sensitivity (+) CD20 + Mature B-Cell Neoplasms Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine